Efficacy and safety of belapectin for the prevention of esophageal varices in patients with MASH cirrhosis: The randomized, placebo-controlled NAVIGATE trial.

Journal:

Hepatology

Published:

2026-05-02

DOI:

10.1097/hep.0000000000001774

Affiliations:

14

Authors:

13

Go to article

Institutions	Authors	Share
Indiana University (IU), United States of America (USA)	2.000000	0.15
Summit Clinical Research, LLC, United States of America (USA)	1.500000	0.12
Coryell Health, United States of America (USA)	1.000000	0.08
Hadassah Medical Center, HUJI, Israel	1.000000	0.08
Texoma Liver Center, United States of America (USA)	1.000000	0.08
St. Mary's Hospital, United States of America (USA)	1.000000	0.08
Centro de Investigación y Gastroenterología, Mexico	1.000000	0.08
Galectin Therapeutics Inc., United States of America (USA)	1.000000	0.08
California Liver Research Institute, United States of America (USA)	1.000000	0.08
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), United States of America (USA)	1.000000	0.08
Houston Methodist Hospital, United States of America (USA)	0.500000	0.04
Houston Research Institute, United States of America (USA)	0.500000	0.04
North Shore Gastroenterology, United States of America (USA)	0.500000	0.04

Interested in Clinical Sciences?